One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel†-Reference-Cited by-同舟云学术

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel†

Published:2005-02-25 Issue:14 Volume:26 Page:1379-1384
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Schömig Albert,Schmitt Claus,Dibra Alban,Mehilli Julinda,Volmer Christian,Schühlen Helmut,Dirschinger Josef,Dotzer Franz,ten Berg Jurriën M.,Neumann Franz-Josef,Berger Peter B.,Kastrati Adnan

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/26/14/1379/9623380/ehi174.pdf

Reference36 articles.

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med1992;326:242–250, 310–318.

2. Mehta SR, Yusuf S. Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol2003;41:79S–88S.

3. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation2000;101:570–80.

4. Lincoff AM, Califf RM, Topol EJ. Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol2000;35:1103–1115.

5. Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson JJ, III, Willerson JT, Weisman HF, Topol EJ. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol2001;37:2059–2065.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease;Journal of Interventional Cardiology;2021-12-01

2. The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention;Journal of Diabetes Research;2021-01-25

3. Novel Anti-Platelets in Stable Coronary Artery Disease;Current Pharmaceutical Design;2016-09-02

4. Heparin is Not Inferior to Bivalirudin in Percutaneous Coronary Intervention—Focusing on the Effect of Glycoprotein IIb/IIIa Inhibitor Use;Angiology;2015-01-29

5. Vascular Complications of Diabetes Mellitus;PanVascular Medicine;2015